Synthesize deviation trends for the next quality review

Distinguish recurring root causes from repeated labels across products, lines and shifts. The QA lead chooses focused investigations and checks whether earlier CAPAs altered the trend.

A request needs specialist review, financial concurrence or delegated approval.

People in the process

QQuality AssuranceProcess Owner

Records it works with

Request, scope and proposed decision
Applicable policy and approval authority
Supporting technical, commercial and control records

The process is a starting point.The standards are yours.

Configure by product, authorisation and destination market. Regulatory Affairs and authorised quality personnel retain product-change, submission and batch-release decisions. Safety reporting and UCPMP requirements use the applicable reviewed scope.

Keep the work connected.

Quality Assurance

Hold batch disposition until exceptions are resolved

Link batch record, QC results, deviations, rework, environmental monitoring and change history. Authorised QA reviews the product-specific impact and decides release, rejection or further investigation.

Quality Assurance

Verify CAPA effectiveness against recurrence evidence

Connect root cause, actions, training, validation and subsequent batches or complaints. QA tests whether the issue actually recurred before approving closure or extending controls.

MEQ

Quality Assurance

Review recurring quality signals across product lots

Assemble batch and analytical trends, deviations, complaints, returns and stability data for the formal product quality review. QA reconciles missing inputs and cross-functional conclusions before approving process or supplier actions.

Explore all Pharma processes.

Order for the work. Room for the people.